Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
Noro Psikiyatri Arsivi|March 13, 2023
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod TreatmentMurat Terzi, Elif Merve Helvacı, Sedat Şen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 yearsJodie I Roberts, Sifat Sharmin, Dana Horakova, et al.Brain : a Journal of Neurology|September 12, 2015
Defining reliable disability outcomes in multiple sclerosisTomas Kalincik, Gary Cutter, Tim Spelman, et al.Annals of Neurology|April 26, 2017
Prognostic indicators in pediatric clinically isolated syndromePietro Iaffaldano, Marta Simone, Giuseppe Lucisano, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2025
Managing reactivation of multiple sclerosis during treatment with natalizumabNathaniel Lizak, Sifat Sharmin, Dana Horáková, et al.JAMA Neurology|June 12, 2023
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple SclerosisIzanne Roos, Stella Hughes, Gavin McDonnell, et al.Multiple Sclerosis and Related Disorders|December 27, 2019
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorderAmy Kunchok, Charles Malpas, Petra Nytrova, et al.Neurology|March 5, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum DisorderPakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt, et al.Neurology|October 7, 2020
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1aFrancesca Bovis, Tomas Kalincik, Fred Lublin, et al.Plos One|June 6, 2015
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MSKaren Ann Ribbons, Patrick McElduff, Cavit Boz, et al.Pageof 16